November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 19, 2024

Does Tetracycline Use in Pregnancy Affect Birth Defects?

Conexiant

November 19, 2024

Gantenerumab Linked to ARIA Risk in Early Alzheimer's Disease

86% of ARIA-E cases occurred within the first 64 weeks of gantenerumab treatment, with APOE ε4 homozygotes showing nearly 5-fold increased risk.

Conexiant

November 19, 2024

MASLD Affects 42% of US Adults, Study Finds

A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.

Conexiant

November 19, 2024

Novel Stroke Drug Shows 12-Hour Window

Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.

Conexiant

November 19, 2024

Cushing’s Patients Have an Increased Risk for Glaucoma, Study Finds

CS patients exhibited a 74% higher overall risk for glaucoma compared to matched controls.

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 18, 2024

Renowned Dermatologist Goldsmith Dies at 86

"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.

Conexiant

November 15, 2024

Global Study Finds Pruritus Affects 40% of Adults Worldwide

Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.

Conexiant